Quick Answer
60 DEGREES PHARMACEUTICALS, INC. reported Gross Profit of $223.8 thousand for fiscal year 2025.
60 DEGREES PHARMACEUTICALS, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $223.8K | +0.4% |
| 2024 | $222.8K | +200.8% |
| 2023 | -$221.0K | -5.6% |
| 2022 | -$209.2K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$100.1K | -524.0% | -296.7% |
| June 30, 2025 | $50.9K | +43.7% | -43.6% |
| March 31, 2025 | $90.3K | +124.4% | +282.4% |
| September 30, 2024 | $23.6K | +218.0% | -33.3% |
| June 30, 2024 | $35.4K | +128.5% | -12.0% |
| March 31, 2024 | $40.2K | +171.9% | +301.1% |
| September 30, 2023 | -$20.0K | — | +83.9% |
| June 30, 2023 | -$124.4K | — | -122.4% |
- 60 DEGREES PHARMACEUTICALS, INC. showed an increase of +0.4% in Gross Profit compared to the prior fiscal year.
- Over the 2022–2025 period, 60 DEGREES PHARMACEUTICALS, INC.’s gross profit has grown by 207.0% (from -$209.2 thousand to $223.8 thousand).
- The most recent figure is from 60 DEGREES PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: